Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Mitotane changes steroid breakdown, affecting cortisol availability.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

A single steroid injection can cause serious side effects like Cushing Syndrome.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Some women with PCOS have rare genetic variants linked to the condition.

The woman was misdiagnosed with Graves Disease, leading to incorrect treatment, while she actually had Pituitary Resistance to Thyroid Hormone.

Rathke’s cleft cysts can rarely cause Cushing disease, and surgery can improve symptoms.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.